https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — People with obesity and alcohol use disorder had fewer heavy drinking days while on semaglutide (Wegovy), a Danish randomized trial showed.
Alongside cognitive behavioral therapy, adults receiving a 2.4-mg weekly dose of the…
